Free Trial
CVE:DMT

Small Pharma (DMT) Stock Price, News & Analysis

Small Pharma logo
C$0.15
-0.01 (-6.25%)
(As of 10/20/2023)

About Small Pharma Stock (CVE:DMT)

Key Stats

Today's Range
C$0.15
C$0.16
50-Day Range
C$0.15
C$0.15
52-Week Range
C$0.06
C$0.22
Volume
1.89 million shs
Average Volume
296,159 shs
Market Capitalization
C$50.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom. As of October 23, 2023, Small Pharma Inc. operates as a subsidiary of Cybin Inc.

Receive DMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter.

DMT Stock News Headlines

LTR Pharma’s SPONTAN Nasal Spray Poised for Global Impact
Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
Small Pharma (CVE:DMT) Trading Down 6.3% - Here's What Happened
See More Headlines

DMT Stock Analysis - Frequently Asked Questions

Small Pharma's stock was trading at C$0.15 on January 1st, 2024. Since then, DMT stock has increased by 0.0% and is now trading at C$0.15.
View the best growth stocks for 2024 here
.

Shares of DMT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Small Pharma investors own include Bombardier, Inc. Class B (BBD.B), Arrival (ARVL), Air Canada (AC), Beyond Meat (BYND), BioSig Technologies (BSGM), Aveanna Healthcare (AVAH) and Actinium Pharmaceuticals (ATNM).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Net Income
C$-19,310,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$-1,162.00
Price / Sales
-43,343.80
Cash Flow
C$0.13 per share
Book Value
C$0.03 per share

Miscellaneous

Free Float
N/A
Market Cap
C$50.37 million
Optionable
Not Optionable
Beta
0.86
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (CVE:DMT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners